Coldstream Capital Management Inc. Takes Position in The Cooper Companies, Inc. (NASDAQ:COO)

Coldstream Capital Management Inc. acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,918 shares of the medical device company’s stock, valued at approximately $208,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Geode Capital Management LLC lifted its holdings in Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock valued at $527,476,000 after purchasing an additional 48,559 shares in the last quarter. Barclays PLC raised its position in shares of Cooper Companies by 0.7% in the third quarter. Barclays PLC now owns 462,947 shares of the medical device company’s stock valued at $51,082,000 after buying an additional 3,070 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its stake in shares of Cooper Companies by 8.1% during the third quarter. Nomura Asset Management Co. Ltd. now owns 58,703 shares of the medical device company’s stock valued at $6,477,000 after buying an additional 4,408 shares during the period. MML Investors Services LLC boosted its position in Cooper Companies by 1.6% during the third quarter. MML Investors Services LLC now owns 17,787 shares of the medical device company’s stock worth $1,963,000 after acquiring an additional 280 shares during the last quarter. Finally, iSAM Funds UK Ltd purchased a new stake in Cooper Companies in the 3rd quarter worth approximately $501,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Insider Transactions at Cooper Companies

In other news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Cooper Companies Stock Up 0.5 %

Shares of Cooper Companies stock opened at $94.49 on Wednesday. The company has a fifty day moving average price of $103.04 and a 200 day moving average price of $99.00. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The stock has a market cap of $18.86 billion, a price-to-earnings ratio of 48.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.87 earnings per share. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on COO shares. Wells Fargo & Company increased their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Robert W. Baird raised their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Stifel Nicolaus restated a “buy” rating and issued a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Piper Sandler increased their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.